ArticleJournal of health monitoring2020
Migraine and tension-type headache in Germany. Prevalence and disease severity from the BURDEN 2020 Burden of Disease Study.
Article in Journal of health monitoring, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- The association between posttraumatic stress disorder and migraine: A systematic review.Headache · 2026Pooled it
- A Prescribed Digital Health App and Number of Migraine Days: A Randomized Clinical Trial.JAMA network open · 2025Trial
- Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON).The journal of headache and pain · 2024Trial
- Drugs for Migraine Prophylaxis.Deutsches Arzteblatt international · 2026Review
- Prevalence of headache disorders in Norway: results from the population based PopHEAD study.The journal of headache and pain · 2025Article
- Headache Management in Military Primary Care: Findings from a Nationwide Cross-Sectional Study.Journal of clinical medicine · 2025Article
- [Fear of migraine attacks: diagnosis and treatment].Schmerz (Berlin, Germany) · 2025Review
- The Impact of Biseasonal Time Changes on Migraine.Neurology international · 2025Article
- Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study.Pain and therapy · 2024Article
- Household income is associated with attack frequency, but not with the prevalence of headache: an analysis of self-reported headache in the general population in Germany.The journal of headache and pain · 2024Article
- Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks.Pain and therapy · 2024Review
- [Gender-specific results of the Dresden children and adolescents headache program DreKiP].Schmerz (Berlin, Germany) · 2024Article
- The increasing significance of disease severity in a burden of disease framework.Scandinavian journal of public health · 2023Article
- Correlation of effectiveness and tolerability assessments from a pharmacy-based observational study investigating the fixed-dose combination of 400 mg ibuprofen plus 100 mg caffeine for the treatment of acute headache.Frontiers in neurology · 2023Article
- Headache and orofacial pain: A traffic-light prognosis-based management approach for the musculoskeletal practice.Frontiers in neurology · 2023Article
- Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline.Neurological research and practice · 2022Article
- A Digital Health Application Allowing a Personalized Low-Glycemic Nutrition for the Prophylaxis of Migraine: Proof-of-Concept Data from a Retrospective Cohort Study.Journal of clinical medicine · 2022Article
- Impact of the Neck and/or Shoulder Pain on Self-reported Headache Treatment Responses - Results From a Pharmacy-Based Patient Survey.Frontiers in neurology · 2022Article
- Prevalence of back and neck pain in Germany. Results from the BURDEN 2020 Burden of Disease Study.Journal of health monitoring · 2021Article
- Reflections on key methodological decisions in national burden of disease assessments.Archives of public health = Archives belges de sante publique · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Headache disorders are widespread among women and men in Germany and are primarily associated with restrictions on quality of life. The two most common types of headache disorders are migraine and tension-type headache. In order to gain valid estimates of the prevalence of these conditions, a cross-sectional telephone-based survey was conducted among adults in Germany (N=5,009) between October 2019 and March 2020. The frequency, duration, the characteristics and comorbidities associated with headache were measured using the diagnostic criteria defined in the International Classification of Headache Disorders. 57.5% of women and 44.4% of men in Germany stated that they had had a headache in the last twelve months. 14.8% of women and 6.0% of men meet all of the diagnostic criteria for migraine. Tension-type headache affects 10.3% of women and 6.5% of men. Migraine and tension-type headache are predominantly found among people of working age and steadily decrease with age. Migraine is often accompanied by comorbidities such as depressive symptoms and anxiety disorders. People affected by headache disorders tend to receive very little professional medical care, with only a minority seeking treatment within a year. These results provide a comprehensive picture of the population-related impact of headache disorders and are used in the BURDEN 2020 study to quantify key indicators for burden of disease assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.